Helmi Sulaiman
edenhelmi.bsky.social
Helmi Sulaiman
@edenhelmi.bsky.social

An ID Physician at Universiti Malaya, Malaysia
Reposted by Helmi Sulaiman
Cefidericol was not inferior for mortality but was the source of all the serious adverse events in this study comparing cefiderocol to standard of care for healthcare-associated GNR blood stream infections.

For CRE subset, verdict less clear… #IDSky

www.thelancet.com/journals/lan...
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised t...
Among patients with a hospital-acquired or health-care-associated Gram-negative bloodstream infection, cefiderocol resulted in non-inferior 14-day mortality compared with standard of care. Adverse eve...
www.thelancet.com
October 11, 2025 at 2:40 PM
Reposted by Helmi Sulaiman
What the DOTS trial of Staph bacteremia tells us:
• Dalbavancin d1 and d8 vs daily IVs for WEEKS
• No left-sided IE/CNS/prosthetics
• Dalba not superior by DOOR endpoint, but similar clinical outcomes.
Big implications for inpt care. More here! #IDSky tinyurl.com/3hjzkt96
DOTS: Optimism Around a “Negative” Dalbavancin Trial
The DOTS randomized clinical trial of dalbavancin versus standard-of-care for Staph aureus bacteremia (SAB) just landed in JAMA, where it undoubtedly will be featured in numerous ID, hospitalist, and ...
tinyurl.com
October 10, 2025 at 10:55 AM
Reposted by Helmi Sulaiman
To change or not to change?

Clinicians please consider this quick (<2 min!!) survey regarding your catheter-associated UTI practice patterns.

My collaborators in 🇳🇱 are exploring practice variations across different countries and medical specialties worldwide.

forms.office.com/e/MRCMwUb2UK
Microsoft Forms
forms.office.com
April 2, 2025 at 2:25 AM
Daily CRP vs daily PCT - which one can help reduce the duration of antibiotic therapy?
Caveat: daily PCT = expensive in LMICs!

A new "paper highlight" on our MAMSIG website
antibiotic-ninja.com/paper-highli...
January 26, 2025 at 9:47 AM
Would you choose cefta-avi or ceftolozane-tazo to treat pneumonia by MDR P. aeruginosa?
We highlighted the CACTUS study published a few weeks ago

www.antibiotic-ninja.com/paper-highli...
January 21, 2025 at 1:35 AM
Reposted by Helmi Sulaiman
New research article in The Lancet Microbe

Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #AMR
January 16, 2025 at 4:02 PM
Reposted by Helmi Sulaiman
In our winter issue: The choice between debridement and implant exchange affects treatment outcomes for Candida-related prosthetic joint infections, highlighting the need for standardized guidelines and research. Yingsi Fang, PharmD and Michael Vala, PharmD offer insights on the topic. #IDsky
Do We Have New Data for Optimal Treatments of Candida-Related Prosthetic Joint Infections?
The choice between debridement and implant exchange affects treatment outcomes for Candida-related prosthetic joint infections, highlighting the need for standardized guidelines and further research.
www.contagionlive.com
January 14, 2025 at 4:34 PM
Reposted by Helmi Sulaiman
WHERE WAS THIS 6 MONTHS AGO WHEN I WAS RESEARCHING OUR TETRACYCLINES EPISODE??!!

Wotevs. Check out this awesome review

Unless u r driving or hate reading; then our episode is here: podcasts.apple.com/gb/podcast/i...

And the episode on the newer agents here: podcasts.apple.com/gb/podcast/i...
January 14, 2025 at 6:29 PM
Reposted by Helmi Sulaiman
Study shows how zinc deprivation makes VIM-2-expressing bacteria more susceptible to azithromycin, offering new treatment options for multidrug-resistant infections. #IDsky #MEDsky

Read more including insights from investigator Meghan Tu: www.contagionlive.com/view/exploit...
Exploiting Zinc Limitation to Combat Carbapenem-Resistant Bacteria
How targeting zinc deprivation in VIM-2-expressing bacteria may open new doors for treating multidrug-resistant infections, with azithromycin showing promise.
www.contagionlive.com
January 14, 2025 at 2:07 PM
Reposted by Helmi Sulaiman
Tetracyclines always been a fascinating antibiotic class. So many different evolutions, and antimicrobial activity that variably spans across Gram pos & neg bacteria, as well as malaria!

Cool review in @cmicomms.bsky.social by @jeffpears0n.bsky.social @bwdionne.bsky.social

#IDSky #clinmicro #AMR
Tetracyclines, the Old and the New: a Narrative Review
Tetracyclines have remained a cornerstone of antimicrobial therapy for over seven decades, demonstrating broad-spectrum activity against a wide range …
www.sciencedirect.com
January 14, 2025 at 12:23 PM
Reposted by Helmi Sulaiman
🔗 References:
1. CLSI M100 ED34:2024, Table 2A-1, Table 2D, Appendix E, Table 2 Dosages
2. Rationale document clsi.org/standards/pr...
MRPKG | Product MRPKG
Rationale Document Package
clsi.org
January 13, 2025 at 3:30 PM
Reposted by Helmi Sulaiman
Who is still using metronidazole q8h for most indications? There’s definitely an opportunity for less frequent dosing most of the time!

I’ve attached my proposal from last year - feel free to take a look, and hopefully it can save you some trouble and doses for you too!

1drv.ms/w/s!AurvlEJP...
November 10, 2024 at 5:14 PM
Reposted by Helmi Sulaiman
Malaysia's MOH and university hospitals report high inpatient antibiotic prescription rates of 45%, mainly in ICUs, outpatient rates are ~5%. Despite concerns, 98% of prescriptions align with national guidelines, reflecting efforts to ensure appropriate use.

codeblue.galencentre.org/2025/01/up-t...
Up To 45% Antibiotic Prescription Rates In MOH, University Hospitals: Health Minister - CodeBlue
MOH and university hospitals report antibiotic prescription rates of 44% to 45.5% for inpatients, mainly driven by ICU wards, says the health minister. In health clinics, antibiotic prescription rates...
codeblue.galencentre.org
January 10, 2025 at 6:26 AM
Has anyone seen NTM infections or difficult-to-diagnose splenic abscesses, presenting as PUO following mesenchymal cell therapy?
January 7, 2025 at 12:34 PM
The 2025 Infection Prevention and Control Workshop is here!
🖐️🦠👩‍⚕️👨‍⚕️
Grab your seats now and learn from the experts about the latest infection control strategies and best practices.
Don’t miss out!
#InfectionPrevention #IPCW2025

Click here to know more: ummctrainings.onpay.my/order/form/i...
January 3, 2025 at 11:04 AM
New year, new paper! 🎉

We’ve summarized the findings from the BALANCE trial, the largest study on BSI to date
#BSI #BALANCETrial

Check it out on the MAMSIG website!
www.antibiotic-ninja.com/paper-highli...
January 3, 2025 at 10:38 AM